Enable Injections, Inc. · 3 hours ago
Engineer III, Product Development
Enable Injections, Inc. is seeking an Engineer III for Product Development. The role involves supporting the design and development of medical devices while ensuring adherence to industry regulations and company procedures.
Health CareLife ScienceManufacturingMedical Device
Responsibilities
Support the design and development of medical devices that adhere to company procedures, industry regulations and customer requirements
Understand and follow the New Product Design process with a focus on quality
Apply mechanical engineering principles and techniques to solve challenges related to product design, manufacturing, assembly, and testing
Contribute to the development of product specifications, drawings, test protocols and reports
Convert user needs to input, develop verification and validation strategies, and conduct risk management activities
Support manufacturing process development
Generate design history files following FDA and international standards
Identify project risks and develop mitigation strategies
May provide technical guidance and coaching of other engineers
Provide project status to leadership
Contributes to internal project planning and execution to meet schedule and budget requirements
Qualification
Required
Bachelor's degree or higher in Mechanical Engineering, Biomedical Engineering, or related field from an accredited university
A minimum of 4 years of product development experience; OR a master's degree in a related field plus 2 years' experience
Preferred
Experience in development and/or manufacturing of medical devices
Experience with plastic injection-molded part design
Proficiency in SolidWorks
Understanding of Geometric Dimensioning and Tolerancing (GD&T)
Company
Enable Injections, Inc.
Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience.
Funding
Current Stage
Growth StageTotal Funding
$352MKey Investors
SanofiMagnetar CapitalORI Capital
2026-01-06Corporate Round· $30M
2022-01-27Series C· $215M
2020-09-08Debt Financing· $25M
Leadership Team
Recent News
vcnewsdaily.com
2026-01-07
2026-01-07
Company data provided by crunchbase